Search

Your search keyword '"Akdis M"' showing total 845 results

Search Constraints

Start Over You searched for: Author "Akdis M" Remove constraint Author: "Akdis M"
845 results on '"Akdis M"'

Search Results

252. Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells.

253. Genes of tolerance.

254. Bacillus Calmette–Guérin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy.

255. EDITORIAL Immunological differences between intrinsic and extrinsic types of atopic dermatitis.

256. Role of dysregulated apoptosis in atopic dermatitis.

257. Critical review of current left ventricular assist devices.

258. Blood pumps for circulatory support.

259. Developmental determinants in non-communicable chronic diseases and ageing.

260. Human Ascaris infection is associated with higher frequencies of IL-10 producing B cells.

262. Enzymatic activity of soluble phospholipase A[sub 2] does not affect the specific...

263. Induction and differential regulation of bee venom phospholipase A "2-specific human IgE and IgG "4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells

264. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom

266. Nature of Regulatory T Cells in the Context of Allergic Disease

267. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

268. MeDALL (Mechanisms of the Development of ALLergy): An integrated approach from phenotypes to systems medicine,MeDALL (Mechanizmy powstawania alergii): Zintegrowane podejście - od fenotypów do medycyny systemowej

269. EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders

272. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

275. MeDALL (Mechanisms of the Development of ALLergy): An integrated approach from phenotypes to systems medicine | MeDALL (Mechanizmy powstawania alergii): Zintegrowane podejście - od fenotypów do medycyny systemowej

278. Mechanisms of allergen-specific immunotherapy

279. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.

280. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis.

281. EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders.

282. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)

285. Mechanisms of immunotherapy to wasp and bee venom.

286. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

287. Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN)

288. Human rhinoviruses enter and induce proliferation of B lymphocytes.

289. Epithelial barrier hypothesis and the development of allergic and autoimmune diseases

290. WITHDRAWN: Scaling up strategies of the Chronic Respiratory Disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3 – Area 5)

291. A novel, dual cytokine-secretion assay for the purification of human Th22 cells that do not co-produce IL-17A.

292. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

293. Pollen-derived nonallergenic substances enhance Th2-induced IgE production in B cells.

294. Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β.

295. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies

296. Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine.

297. Global Allergy Forum and Second Davos Declaration 2013 Allergy: Barriers to cure - challenges and actions to be taken.

298. Distinct regulation of tonsillar immune response in virus infection.

299. ARIA���EAACI statement on asthma and COVID���19 (June 2, 2020)

300. MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine.

Catalog

Books, media, physical & digital resources